Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions

Vaccine

Volumn 27, Issue 31, 2009, Pages 4118-4126

  Gethmann, J ^a   Huttner K ^c   Heyne, H ^b   Probst, C ^a   Ziller, M ^a   Beer, M ^a   Hoffmann, B ^a   Mettenleiter, T C ^a   Conraths, F J ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b Environment and Rural Areas the State of Schleswig Holstein   (Germany)

^c State Office for Agriculture   (Germany)

Author keywords

Bluetongue; Inactivated vaccine; Safety study; Vaccination

Indexed keywords

ALUMINUM HYDROXIDE; BLUEVAC; BTVPUR; INACTIVATED VACCINE; SAPONIN; UNCLASSIFIED DRUG; VIRUS VACCINE; ZULVAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLUETONGUE ORBIVIRUS; BODY TEMPERATURE; CATTLE; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FEVER; GERMANY; HUMORAL IMMUNITY; INJECTION SITE REACTION; MALE; MILK PRODUCTION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SHEEP; SHEEP DISEASE; SINGLE DRUG DOSE; SOMATIC CELL; STATISTICAL ANALYSIS; VACCINATION;

ANIMALS; BLUETONGUE; BLUETONGUE VIRUS; CATTLE; FEMALE; GERMANY; MALE; SHEEP; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 67349160450     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.072     Document Type: Article

References (23)

1. Batten C.A., Sanders A.J., Bachanek-Bankowska K., Bin-Tarif A., and Oura C.A.L. Bluetongue virus: European community inter-laboratory comparison tests to evaluate ELISA and RT-PCR detection methods. Vet Microbiol 129 (2008) 80-88
2. Dedie K., and Bostedt H. Schaf- und Ziegenkrankheiten (1996), UTB, Stuttgart
3. Di Emidio B., Nicolussi P., Patta C., Ronchi G.F., Monaco F., Savini G., et al. Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2. Vet Ital 40 4 (2004) 640-644
4. Enserink M. Exotic disease of farm animal tests Europe's responses. Science 319 5964 (2008) 710-711
5. European Pharmacopoeia 6.0. Chapter 5.2.6: Evaluation of safety of veterinary vaccines and immunosera; 2007. p. 556-7.
6. EFSA (2007). Scientific Report of the Scientific Panel on Animal Health and Welfare on request from the Commission (EFSA-Q-2006-311) and EFSA Selfmandate (EFSA-Q-2007-063) on bluetongue.
7. García de la Fuente J.N., Gutiérrez-Martín C.B., Ortega N., Rodríguez-Ferri E.F., del Río M.L., González O.R., et al. Efficacy of different commercial and new inactivated vaccines against ovine enzootic abortion. Vet Microbiol 100 (2004) 65-76
8. Green M.J., Bradley A.J., Newton H., and Browne W.J. Seasonal variation of bulk milk somatic cell counts in UK dairy herds: Investigations of the summer rise. Prev Vet Med 74 (2006) 293-308
9. Johnson S.J., Polkinghorne I.G., Flanagan M., and Townsend W.L. The Australian experience: results of a bluetongue vaccination program. In: Walton T.E., and Osburn B.I. (Eds). Bluetongue, African Horse Sickness and Related Orbiviruses (1992), CRC Press, Boca Raton 868-873
10. Nøkleby H., Aavitsland P., ÓHallahan J., Feiring B., Tilman S., and Oster P. Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease. Vaccine 25 16 (2007) 3080-3084
11. Norman H.D., Miller R.H., Wright J.R., and Wiggans G.R. Herd and state means for somatic cell count from dairy herd improvement. J Dairy Sci 83 (2000) 2782-2788
12. Parrott R.F., Lloyd D.M., and Brown D. Transport stress and exercise hyperthermia recorded in sheep by radiotelemetry. Anim Welf 8 1 (1999) 27-34
13. Ramakrishnan M.A., Pandey A.B., Singh K.P., Singh R., Nandi S., and Mehrotra M.L. Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep. Vet Res Commun 30 November (8) (2006) 873-880
14. Rosenberger G. Die klinische Untersuchung des Rindes (1990), Paul Parey, Berlin/Hamburg
15. Saegerman C., Hubaux M., Urbain B., Lengelé L., and Berkvens D. Regulatory issues surrounding the temporary authorization of animal vaccination in emergency situations: the example of bluetongue in Europe. Rev Sci Tech Off Int Epiz 26 2 (2007) 395-413
16. Saegerman C., Berkvens D., and Mellor P.S. Bluetongue Epidemiology in the European Union. Emerg Infect Dis 14 4 (2008) 539-544
17. Savini G., Hamers C., Conte A., Migliaccio P., Bonfini B., Teodori L., et al. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet Microbiol 133 1-2 (2009) 1-8
18. Savini G., MacLachlan N.J., Sanchez-Vizcaino J.M., and Zientara S. Vaccines against bluetongue in Europe. Comp Immunol Microbiol 31 (2008) 101-120
19. Savini G., Ronchi G.F., Leone A., Ciarelli A., Migliaccio P., Franchi P., et al. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy. Vet Microbiol 124 1-2 (2007) 140-146
20. Schwartz-Cornil I., Mertens P.C., Contreras V., Hemati B., Pascale F., Bréard E., et al. Bluetongue virus: virology, pathogenesis and immunity. Vet Res 39 5 (2008) 39-46
21. Stott J.L., Barber T.L., and Osburn B.I. Immunologic response of sheep to inactivated and virulent bluetongue virus. Am J Vet Res 45 (1985) 1043-1049
22. Veronesi E., Hamblin C., and Mellor P.S. Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae). Vaccine 23 (2005) 5509-5516
23. Yeruham I., Yadin H., Haymovich M., and Perl S. Adverse reactions to FMD vaccine. Vet Dermatol 12 (2001) 197-201